Cargando…
Cathepsin S activation contributes to elevated CX3CL1 (fractalkine) levels in tears of a Sjögren’s syndrome murine model
Autoimmune dacryoadenitis and altered lacrimal gland (LG) secretion are features of Sjögren’s syndrome (SS). Activity of cathepsin S (CTSS), a cysteine protease, is significantly and specifically increased in SS patient tears. The soluble chemokine, CX3CL1 (fractalkine), is cleaved from membrane-bou...
Autores principales: | Fu, Runzhong, Guo, Hao, Janga, Srikanth, Choi, Minchang, Klinngam, Wannita, Edman, Maria C., Hamm-Alvarez, Sarah F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6989636/ https://www.ncbi.nlm.nih.gov/pubmed/31996771 http://dx.doi.org/10.1038/s41598-020-58337-4 |
Ejemplares similares
-
Cathepsin S Alters the Expression of Pro-Inflammatory Cytokines and MMP-9, Partially through Protease—Activated Receptor-2, in Human Corneal Epithelial Cells
por: Klinngam, Wannita, et al.
Publicado: (2018) -
Inhibition of Cathepsin S Reduces Lacrimal Gland Inflammation and Increases Tear Flow in a Mouse Model of Sjögren’s Syndrome
por: Klinngam, Wannita, et al.
Publicado: (2019) -
Interferon-γ treatment in vitro elicits some of the changes in cathepsin S and antigen presentation characteristic of lacrimal glands and corneas from the NOD mouse model of Sjögren’s Syndrome
por: Meng, Zhen, et al.
Publicado: (2017) -
Rapamycin Eye Drops Suppress Lacrimal Gland Inflammation In a Murine Model of Sjögren's Syndrome
por: Shah, Mihir, et al.
Publicado: (2017) -
Fractalkine/CX3CL1 in Neoplastic Processes
por: Korbecki, Jan, et al.
Publicado: (2020)